Barriers, vaccine hesitancy and attitudes towards the to the covid-19 vaccine in Türkiye

Barriers, vaccine hesitancy and attitudes towards the to the covid-19 vaccine in Türkiye

This study aimed to determine the barriers, vaccine hesitancy and attitudes towards the to the COVID-19 vaccine in Türkiye. A cross-sectional study included 2031 people aged 18 years and older living in Türkiye. Data were collected through an online questionnaire created by the researchers in line w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:HEALTH SCIENCES QUARTERLY 2024-01, Vol.4 (1), p.11-20
Hauptverfasser: Yalçın Gürsoy, Melike, Chousko Mechmet, Fatme
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 20
container_issue 1
container_start_page 11
container_title HEALTH SCIENCES QUARTERLY
container_volume 4
creator Yalçın Gürsoy, Melike
Chousko Mechmet, Fatme
description This study aimed to determine the barriers, vaccine hesitancy and attitudes towards the to the COVID-19 vaccine in Türkiye. A cross-sectional study included 2031 people aged 18 years and older living in Türkiye. Data were collected through an online questionnaire created by the researchers in line with the literature and the Attitudes towards the COVID-19 Vaccine (ATV-COVID-19) scale. In total, 1043 participants (51.4%) defined themselves as vaccine hesitant. The most-motivating factor for vaccination was protecting self and family, while thinking that vaccines are unsafe was the most common barrier against vaccination. Compared to females, being male (OR=0.770) had a 1.3-times (1/0.770) protective effect from vaccination hesitancy, while one unit increase in the ATV-COVID-19 score (OR=0.080) was 12.5-times (1/0.080) protective. As a result of the study, it was observed that there was a high level of vaccine hesitancy due to mistrust of COVID-19 vaccines or fear of side effects. In addition, vaccine hesitancy was associated with gender and the level of attitude towards the vaccine.
doi_str_mv 10.26900/hsq.2113
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_26900_hsq_2113</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_26900_hsq_2113</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_26900_hsq_21133</originalsourceid><addsrcrecordid>eNqVjsEOwUAURSdCQrDwB7OVKDNTaXVLiA-wsZqM6TR9Qct7g_Tf7PyYEhFbq3MW9yaHsYEUYxUlQkxyOo-VlGGDdVScyCASSjV_vM36RLAT02kczsJEdth2bhDBIY341VgLheO5I_CmsBU3RcqN9-AvqSPuy5vBtGbuan_DlldIA5l8v1DwzeOOe6hcj7UycyDX_7DLhqvlZrEOLJZE6DJ9QjgarLQU-p2v63z9yg__2T4B8yJMtQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Barriers, vaccine hesitancy and attitudes towards the to the covid-19 vaccine in Türkiye</title><source>Alma/SFX Local Collection</source><creator>Yalçın Gürsoy, Melike ; Chousko Mechmet, Fatme</creator><creatorcontrib>Yalçın Gürsoy, Melike ; Chousko Mechmet, Fatme</creatorcontrib><description>This study aimed to determine the barriers, vaccine hesitancy and attitudes towards the to the COVID-19 vaccine in Türkiye. A cross-sectional study included 2031 people aged 18 years and older living in Türkiye. Data were collected through an online questionnaire created by the researchers in line with the literature and the Attitudes towards the COVID-19 Vaccine (ATV-COVID-19) scale. In total, 1043 participants (51.4%) defined themselves as vaccine hesitant. The most-motivating factor for vaccination was protecting self and family, while thinking that vaccines are unsafe was the most common barrier against vaccination. Compared to females, being male (OR=0.770) had a 1.3-times (1/0.770) protective effect from vaccination hesitancy, while one unit increase in the ATV-COVID-19 score (OR=0.080) was 12.5-times (1/0.080) protective. As a result of the study, it was observed that there was a high level of vaccine hesitancy due to mistrust of COVID-19 vaccines or fear of side effects. In addition, vaccine hesitancy was associated with gender and the level of attitude towards the vaccine.</description><identifier>ISSN: 2791-6022</identifier><identifier>EISSN: 2791-6022</identifier><identifier>DOI: 10.26900/hsq.2113</identifier><language>eng</language><ispartof>HEALTH SCIENCES QUARTERLY, 2024-01, Vol.4 (1), p.11-20</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-crossref_primary_10_26900_hsq_21133</cites><orcidid>0000-0002-2246-264X ; 0000-0003-3034-3808</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Yalçın Gürsoy, Melike</creatorcontrib><creatorcontrib>Chousko Mechmet, Fatme</creatorcontrib><title>Barriers, vaccine hesitancy and attitudes towards the to the covid-19 vaccine in Türkiye</title><title>HEALTH SCIENCES QUARTERLY</title><description>This study aimed to determine the barriers, vaccine hesitancy and attitudes towards the to the COVID-19 vaccine in Türkiye. A cross-sectional study included 2031 people aged 18 years and older living in Türkiye. Data were collected through an online questionnaire created by the researchers in line with the literature and the Attitudes towards the COVID-19 Vaccine (ATV-COVID-19) scale. In total, 1043 participants (51.4%) defined themselves as vaccine hesitant. The most-motivating factor for vaccination was protecting self and family, while thinking that vaccines are unsafe was the most common barrier against vaccination. Compared to females, being male (OR=0.770) had a 1.3-times (1/0.770) protective effect from vaccination hesitancy, while one unit increase in the ATV-COVID-19 score (OR=0.080) was 12.5-times (1/0.080) protective. As a result of the study, it was observed that there was a high level of vaccine hesitancy due to mistrust of COVID-19 vaccines or fear of side effects. In addition, vaccine hesitancy was associated with gender and the level of attitude towards the vaccine.</description><issn>2791-6022</issn><issn>2791-6022</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqVjsEOwUAURSdCQrDwB7OVKDNTaXVLiA-wsZqM6TR9Qct7g_Tf7PyYEhFbq3MW9yaHsYEUYxUlQkxyOo-VlGGDdVScyCASSjV_vM36RLAT02kczsJEdth2bhDBIY341VgLheO5I_CmsBU3RcqN9-AvqSPuy5vBtGbuan_DlldIA5l8v1DwzeOOe6hcj7UycyDX_7DLhqvlZrEOLJZE6DJ9QjgarLQU-p2v63z9yg__2T4B8yJMtQ</recordid><startdate>20240125</startdate><enddate>20240125</enddate><creator>Yalçın Gürsoy, Melike</creator><creator>Chousko Mechmet, Fatme</creator><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-2246-264X</orcidid><orcidid>https://orcid.org/0000-0003-3034-3808</orcidid></search><sort><creationdate>20240125</creationdate><title>Barriers, vaccine hesitancy and attitudes towards the to the covid-19 vaccine in Türkiye</title><author>Yalçın Gürsoy, Melike ; Chousko Mechmet, Fatme</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_26900_hsq_21133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Yalçın Gürsoy, Melike</creatorcontrib><creatorcontrib>Chousko Mechmet, Fatme</creatorcontrib><collection>CrossRef</collection><jtitle>HEALTH SCIENCES QUARTERLY</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yalçın Gürsoy, Melike</au><au>Chousko Mechmet, Fatme</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Barriers, vaccine hesitancy and attitudes towards the to the covid-19 vaccine in Türkiye</atitle><jtitle>HEALTH SCIENCES QUARTERLY</jtitle><date>2024-01-25</date><risdate>2024</risdate><volume>4</volume><issue>1</issue><spage>11</spage><epage>20</epage><pages>11-20</pages><issn>2791-6022</issn><eissn>2791-6022</eissn><abstract>This study aimed to determine the barriers, vaccine hesitancy and attitudes towards the to the COVID-19 vaccine in Türkiye. A cross-sectional study included 2031 people aged 18 years and older living in Türkiye. Data were collected through an online questionnaire created by the researchers in line with the literature and the Attitudes towards the COVID-19 Vaccine (ATV-COVID-19) scale. In total, 1043 participants (51.4%) defined themselves as vaccine hesitant. The most-motivating factor for vaccination was protecting self and family, while thinking that vaccines are unsafe was the most common barrier against vaccination. Compared to females, being male (OR=0.770) had a 1.3-times (1/0.770) protective effect from vaccination hesitancy, while one unit increase in the ATV-COVID-19 score (OR=0.080) was 12.5-times (1/0.080) protective. As a result of the study, it was observed that there was a high level of vaccine hesitancy due to mistrust of COVID-19 vaccines or fear of side effects. In addition, vaccine hesitancy was associated with gender and the level of attitude towards the vaccine.</abstract><doi>10.26900/hsq.2113</doi><orcidid>https://orcid.org/0000-0002-2246-264X</orcidid><orcidid>https://orcid.org/0000-0003-3034-3808</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 2791-6022
ispartof HEALTH SCIENCES QUARTERLY, 2024-01, Vol.4 (1), p.11-20
issn 2791-6022
2791-6022
language eng
recordid cdi_crossref_primary_10_26900_hsq_2113
source Alma/SFX Local Collection
title Barriers, vaccine hesitancy and attitudes towards the to the covid-19 vaccine in Türkiye
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T17%3A58%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Barriers,%20vaccine%20hesitancy%20and%20attitudes%20towards%20the%20to%20the%20covid-19%20vaccine%20in%20T%C3%BCrkiye&rft.jtitle=HEALTH%20SCIENCES%20QUARTERLY&rft.au=Yal%C3%A7%C4%B1n%20G%C3%BCrsoy,%20Melike&rft.date=2024-01-25&rft.volume=4&rft.issue=1&rft.spage=11&rft.epage=20&rft.pages=11-20&rft.issn=2791-6022&rft.eissn=2791-6022&rft_id=info:doi/10.26900/hsq.2113&rft_dat=%3Ccrossref%3E10_26900_hsq_2113%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true